Regression with nonstationary volatilityHANSEN, B. E.Econometrica. 1995, Vol 63, Num 5, pp 1113-1132, issn 0012-9682Article

Threshold effects in non-dynamic panels : Estimation, testing, and inferenceHANSEN, B. E.Journal of econometrics. 1999, Vol 93, Num 2, pp 345-368, issn 0304-4076Article

Inference when a nuisance parameter is not identified under the null hypothesisHANSEN, B. E.Econometrica. 1996, Vol 64, Num 2, pp 413-430, issn 0012-9682Article

Efficient estimation and testing of cointegrating vectors in the presence of deterministic trendsHANSEN, B. E.Journal of econometrics. 1992, Vol 53, Num 1-3, pp 87-121, issn 0304-4076Article

Sample splitting and threshold estimationHANSEN, B. E.Econometrica. 2000, Vol 68, Num 3, pp 575-603, issn 0012-9682Article

Consistent covariance matrix estimation for dependent heterogeneous processesHANSEN, B. E.Econometrica. 1992, Vol 60, Num 4, pp 967-972, issn 0012-9682Article

Testing for structural change in conditional modelsHANSEN, B. E.Journal of econometrics. 2000, Vol 97, Num 1, pp 93-115, issn 0304-4076Article

Heteroskedastic cointegrationHANSEN, B. E.Journal of econometrics. 1992, Vol 54, Num 1-3, pp 139-158, issn 0304-4076Article

Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosisSPAANDER, M. C. W; VAN BUUREN, H. R; HANSEN, B. E et al.Alimentary pharmacology & therapeutics. 2010, Vol 32, Num 4, pp 529-534, issn 0269-2813, 6 p.Article

Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal flstulae in Crohn's disease with infliximab: a double-blind placebo-controlled studyWEST, R. L; VAN DER WOUDE, C. J; HANSEN, B. E et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 11-12, pp 1329-1336, issn 0269-2813, 8 p.Article

Durability of HBeAg seroconversion following antiviral therapy or chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseVAN NUNEN, A. B; HANSEN, B. E; SCHALM, S. W et al.Gut. 2003, Vol 52, Num 3, pp 420-424, issn 0017-5749, 5 p.Article

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosisVAN HOOGSTRATEN, H. J. F; HANSEN, B. E; VAN BUUREN, H. R et al.Journal of hepatology. 1999, Vol 31, Num 2, pp 256-262, issn 0168-8278Article

Efficacy of interferon dose and prediction of response in chronic hepatitis C : Benelux study in 336 patientsBROUWER, J. T; NEVENS, F; WEBER, J et al.Journal of hepatology. 1998, Vol 28, Num 6, pp 951-959, issn 0168-8278Article

Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cellsVAN TOL, E. A. F; VERSPAGET, H. W; HANSEN, B. E et al.Journal of neuroimmunology. 1993, Vol 42, Num 2, pp 139-145, issn 0165-5728Article

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis BBROUWER, W. P; SONNEVELD, M. J; BOONSTRA, A et al.Alimentary pharmacology & therapeutics. 2014, Vol 40, Num 7, pp 811-818, issn 0269-2813, 8 p.Article

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertensionSCHOUTEN, J. N. L; VAN DER ENDE, M. E; KOËTER, T et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 9, pp 875-885, issn 0269-2813, 11 p.Article

Perianal fistulas in crohn's disease are predominantly colonized by skin flora : Implications for antibiotic treatment?WEST, R. L; VAN DER WOUDE, C. J; ENDTZ, H. Ph et al.Digestive diseases and sciences. 2005, Vol 50, Num 7, pp 1260-1263, issn 0163-2116, 4 p.Article

Extrahepatic portal vein thrombosis : aetiology and determinants of survivalJANSSEN, H. L. A; WIJNHOUD, A; ROSENDAAL, F. R et al.Gut. 2001, Vol 49, Num 5, pp 720-724, issn 0017-5749Article

The renal histopathology in systemic vasculitis : an international survey study of inter- and intra-observer agreementBAJEMA, I. M; HAGEN, E. C; HANSEN, B. E et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 10, pp 1989-1995, issn 0931-0509Article

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis CDE KNEGT, R. J; BEZEMER, G; VAN GOOL, A. R et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 11-12, pp 1306-1317, issn 0269-2813, 12 p.Article

Oesophagitis is common in patients with achalasia after pneumatic dilatationLEEUWENBURGH, I; VAN DEKKEN, H; SCHOLTEN, P et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 8, pp 1197-1203, issn 0269-2813, 7 p.Article

Can three-dimensional endoanal ultrasonography detect external anal sphincter atrophy? A comparison with endoanal magnetic resonance imagingWEST, R. L; DWARKASING, S; BRIEL, J. W et al.International journal of colorectal disease (Print). 2005, Vol 20, Num 4, pp 328-333, issn 0179-1958, 6 p.Article

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B : predictive factors for dose reduction and treatment discontinuationVAN ZONNEVELD, M; FLINK, H. J; DE MAN, R. A et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 9, pp 1163-1171, issn 0269-2813, 9 p.Article

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during peg-interferon α-2b therapyFLINK, H. J; SPRENGERS, D; HANSEN, B. E et al.Gut. 2005, Vol 54, Num 11, pp 1604-1609, issn 0017-5749, 6 p.Article

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohortWOLTERS, L. M. M; NIESTERS, H. G. M; HANSEN, B. E et al.Journal of clinical virology. 2002, Vol 24, Num 3, pp 173-181, issn 1386-6532Article